Research graph
References from Re-evaluating aglatimagene in localised prostate cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial
10.1016/s1470-2045(26)00071-9 · 2026 · External reference
Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis
10.1038/s41391-021-00323-6 · 2021 · External reference
Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial
10.1016/j.eururo.2017.12.017 · 2018 · External reference
Perioperative apalutamide in high-risk localized prostate cancer
10.1056/nejmoa2603878 · 2026 · External reference
Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review
10.1016/s0022-5347(05)00957-2 · 2006 · External reference
Practice patterns of primary EBRT with and without ADT in prostate cancer treatment
10.1038/s41391-018-0084-3 · 2019 · External reference
